Brief: Avita Medical Announces Topline Results From Pivotal Trial In Patients With Soft-Tissue Injuries Using The Recell System
11/08/2022 21:38
Aug 11 (Reuters) - AVITA Medical Inc RCEL.O :
* AVITA MEDICAL ANNOUNCES TOPLINE RESULTS FROM PIVOTAL TRIAL
IN
PATIENTS WITH SOFT-TISSUE INJURIES USING THE RECELL® SYSTEM
* AVITA MEDICAL INC - AVITA MEDICAL PLANS TO SUBMIT PMA
SUPPLEMENT
FOR THE NEW INDICATION TO FDA BY END OF 2022
Source text for Eikon: ID:nGNX7x68mT
Further company coverage: RCEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AVITA Medical
See all newsAvita Medical Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: AVITA Medical Q1 EPS USD -0.35
Brief: AVITA Medical Q4 EPS USD -0.38
Brief: Avita Medical Inc - Enters Into Credit Agreement And Guaranty - SEC Filing